[Comparative evaluation of the anti-arrhythmia effect of the antioxidant ionol (dibunol) in the arrhythmic form of neurocirculatory asthenia and stable exertion-induced stenocardia].
Meerson
F Z
FZ
Korochkin
I M
IM
Barbarash
O L
OL
D000293:Adolescent; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D000975:Antioxidants / Q000627:therapeutic use*; D002084:Butylated Hydroxytoluene / Q000627:therapeutic use*; D005117:Cardiac Complexes, Premature / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002986:Clinical Trials as Topic; D005080:Exercise Test; D006801:Humans; D008875:Middle Aged; D009449:Neurocirculatory Asthenia / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology; D005082:Physical Exertion / Q000502:physiology; D013617:Tachycardia, Supraventricular / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D014938:Work Capacity Evaluation
D000889:Anti-Arrhythmia Agents; D000975:Antioxidants; D002084:Butylated Hydroxytoluene
Sravnitel'naia otsenka antiaritmicheskogo éffekta antioksidanta ionola (dibunola) pri aritmicheskoĭ forme neĭrotsirkuliatornoĭ distonii i stabil'noĭ stenokardii napriazheniia.